Oral Abstract Session
Shaping Pediatric Kidney Disease: Developmental Insights, Stem Cell Systems, Novel Biomarkers, and More
October 22, 2026 | 04:30 PM - 06:00 PM
Location: Room 603, Convention Center
Session Description
Oral Abstract Session
Learning Pathway(s)
- Pediatric Nephrology
Moderators
Presentations
Redefining the Origin and Lineage Fate Decisions Required for Metanephric Mesenchyme Specification
Glomerular Endothelial Metabolic Reprogramming in Alport Syndrome: Aberrant Mitochondrial Oxidative Phosphorylation (OXPHOS) Activation and Extracellular Vesicle-Mediated Rescue
Lectin and Terminal Pathway Activation in Children with IgAN
Pretreatment Antinephrin Antibody Titers Stratify Nephrotic Syndrome in Pediatric Patients and Predict Steroid Response, Independent of Genetic Risk Alleles
Pax2 Regulates a Transitional Parietal Epithelial Cell/Podocyte Cell State During Glomerular Repair via Nell-2
Urinary Cell-Free DNA Methylation Signatures of CKD Progression of Congenital Anomalies of the Kidney and Urinary Tract in Pediatric Patients
CKD in Pediatric Patients: From Targeted Proteomics to Network-Based Modeling of Inflammatory Signatures
Aortic Stiffness Index by Echocardiography: An Early Clinical Marker of Vascular Stiffness in Pediatric Patients with CKD
AKI in Neonates in the Modern Era: Preliminary Results from the Multinational AWAKEN 2.0 Cohort